ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2B Clinical Trial Posted on March 31, 2022 by ARCA IT - Press Release, Uncategorized 3.31-ASPEN-COVID-19-Phase-2B-Data-FINAL
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update Posted on March 14, 2022 by ARCA IT - Press Release, Uncategorized 3.14-2021-Financial-Results-and-Business-Update
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2 Posted on January 4, 2022 by ARCA IT - Press Release, Uncategorized 1.4-Gencaro-Data-Published-in-Heart-Rhythm-O2
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19 Posted on December 2, 2021 by ARCA IT - Press Release, Uncategorized 12.2-ASPEN-COVID-19-trial-enrollment-completion
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th Posted on November 9, 2021 by ARCA IT - Press Release, Uncategorized 11.9-Q4-Virtual-Investor-Summit-Annc-FINAL
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update Posted on November 2, 2021 by ARCA IT - Press Release, Uncategorized 11.2-3Q2021-Financial-Results-and-Business-Update
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety Data Posted on October 28, 2021 by ARCA IT - Press Release, Uncategorized 10.28-ASPEN-COVID-trial-interim-analysis-FINAL
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 Posted on September 16, 2021 by ARCA IT - Press Release, Uncategorized 9.16-rNAPc2-ASPEN-COVID-South-America-FPE
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th Posted on August 16, 2021 by ARCA IT - Press Release, Uncategorized 8.16-Q3-Virtual-Investor-Summit-Annc
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2 Posted on August 9, 2021 by ARCA IT - Press Release, Uncategorized 8.9-rNAPc2-COVID-19-Patent-submission-FINAL